Aspire Biopharma Holdings, Inc. (ASBP): SCHEDULE 13G/A filed May 13, 2026

Name: Aspire Biopharma Holdings, Inc. SCHEDULE 13G/A (0001213900-26-055622)
Creator: Aspire Biopharma Holdings, Inc.
Published: 2026-05-13

Form type: SCHEDULE 13G/A
Filing date: May 13, 2026
Accession number: 0001213900-26-055622
Filer: Aspire Biopharma Holdings, Inc. (CIK 1847345)